Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial
- 21 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 46 (9), 1643-1649
- https://doi.org/10.1038/s41386-021-00984-w
Abstract
Post-traumatic stress disorder (PTSD) is difficult to treat but one promising strategy is to block memory reconsolidation of the traumatic event. This study aimed to evaluate the efficacy of traumatic memory reactivation under the influence of propranolol, a noradrenergic beta-receptor blocker, in reducing PTSD symptoms as well as comorbid major depression (MD) symptoms. We conducted a double blind, placebo-controlled, randomised clinical trial in 66 adults diagnosed with longstanding PTSD. Propranolol or a placebo was administered 90 min before a brief memory reactivation session, once a week for 6 consecutive weeks. Measures included the SCID PTSD module, the PTSD Check List (PCL-S) and the Beck Depression Inventory-II (BDI-II). PTSD symptoms decreased both in the pre-reactivation propranolol group (39.28%) and the pre-reactivation placebo group (34.48 %). During the 6 treatment sessions, PCL-S and BDI-II scores decreased to similar extent in both groups and there were no treatment differences. During the 3-month follow-up period, there were no treatment effects for the mean PCL-S and BDI-II scores. However, in patients with severe PTSD symptoms (PCL-S ≥ 65) before treatment, PCL-S and BDI-II scores continued to decline 3 months after the end of treatment in the propranolol group while they increased in the placebo group. Repeated traumatic memory reactivation seemed to be effective for PTSD and comorbid MD symptoms. However, the efficacy of propranolol was not greater than that of placebo 1 week post treatment. Furthermore, in this traumatic memory reactivation, PTSD symptom severity at baseline might have influenced the post-treatment effect of propranolol.This publication has 39 references indexed in Scilit:
- Propranolol’s effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysisJournal of Psychiatry and Neuroscience, 2013
- Trauma Reactivation Under the Influence of Propranolol Decreases Posttraumatic Stress Symptoms and DisorderJournal of Clinical Psychopharmacology, 2011
- Neural mechanisms of the cognitive model of depressionNature Reviews Neuroscience, 2011
- Noradrenergic enhancement of reconsolidation in the amygdala impairs extinction of conditioned fear in rats-a possible mechanism for the persistence of traumatic memories in PTSDDepression and Anxiety, 2011
- Does Reconsolidation Occur in Humans: A ReplyFrontiers in Behavioral Neuroscience, 2011
- Beyond extinction: erasing human fear responses and preventing the return of fearNature Neuroscience, 2009
- Memory Reconsolidation and Extinction Have Distinct Temporal and Biochemical SignaturesJournal of Neuroscience, 2004
- SSRIs versus Non-SSRIs in Post-traumatic Stress DisorderDrugs, 2004
- Partial Response and Nonresponse to Antidepressant TherapyPublished by Physicians Postgraduate Press, Inc ,2002
- Relationship between plasma propranolol concentration and dose in young, healthy volunteersBiopharmaceutics & Drug Disposition, 1986